High drug loading and pH-responsive nanomedicines driven by dynamic boronate covalent chemistry for potent cancer immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High drug loading and pH-responsive nanomedicines driven by dynamic boronate covalent chemistry for potent cancer immunotherapy
Authors
Keywords
-
Journal
Nano Research
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-09
DOI
10.1007/s12274-021-3314-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
- (2020) John D. Martin et al. Nature Reviews Clinical Oncology
- Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma
- (2020) Zhuo Yu et al. ACS Nano
- Design and discovery of boronic acid drugs
- (2020) Jessica Plescia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Eliciting Immunogenic Cell Death via a Unitized Nanoinducer
- (2020) Zan Dai et al. NANO LETTERS
- Nanotechnologies for enhancing cancer immunotherapy
- (2020) Jingxian Yang et al. Nano Research
- A Combinative Assembly Strategy Inspired Reversibly Borate-Bridged Polymeric Micelles for Lesion-Specific Rapid Release of Anti-Coccidial Drugs
- (2020) Hao Cheng et al. Nano-Micro Letters
- Tumor‐Activated Size‐Enlargeable Bioinspired Lipoproteins Access Cancer Cells in Tumor to Elicit Anti‐Tumor Immune Responses
- (2020) Jie Li et al. ADVANCED MATERIALS
- Sonodynamic therapy with immune modulatable two-dimensional coordination nanosheets for enhanced anti-tumor immunotherapy
- (2020) Wenjun Zhu et al. Nano Research
- Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
- (2019) Qian Chen et al. ADVANCED MATERIALS
- Ecto-calreticulin is essential for an efficient immunogenic cell death stimulation in mouse melanoma
- (2019) Thomas Brunner GENES AND IMMUNITY
- Bortezomib Dendrimer Prodrug-Based Nanoparticle System
- (2019) Xuefeng Hu et al. ADVANCED FUNCTIONAL MATERIALS
- Combining Nanomedicine and Immunotherapy
- (2019) Yang Shi et al. ACCOUNTS OF CHEMICAL RESEARCH
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Materials for Immunotherapy
- (2019) C. Wyatt Shields et al. ADVANCED MATERIALS
- Crizotinib-induced immunogenic cell death in non-small cell lung cancer
- (2019) Peng Liu et al. Nature Communications
- Cold to Hot: Rational Design of a Minimalist Multifunctional Photo-immunotherapy Nanoplatform toward Boosting Immunotherapy Capability
- (2019) Di Zhang et al. ACS Applied Materials & Interfaces
- Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment
- (2019) Yayu Wen et al. ACS Applied Materials & Interfaces
- Sustained Delivery of Carfilzomib by Tannic Acid-Based Nanocapsules Helps Develop Antitumor Immunity
- (2019) Maie S. Taha et al. NANO LETTERS
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Polymer nanoparticles as adjuvants in cancer immunotherapy
- (2018) Shengxian Li et al. Nano Research
- Foe to Friend: Supramolecular Nanomedicines Consisting of Natural Polyphenols and Bortezomib
- (2018) Changping Wang et al. NANO LETTERS
- Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy
- (2018) Jianhua Zhu et al. Nanoscale
- A Targeted and pH-Responsive Bortezomib Nanomedicine in the Treatment of Metastatic Bone Tumors
- (2018) Mingming Wang et al. ACS Applied Materials & Interfaces
- Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
- (2017) Leisha A. Emens et al. EUROPEAN JOURNAL OF CANCER
- Carfilzomib versus bortezomib: no longer an ENDEAVOR
- (2017) Niels WCJ van de Donk LANCET ONCOLOGY
- Breaking Down the Barriers to Precision Cancer Nanomedicine
- (2017) Christina von Roemeling et al. TRENDS IN BIOTECHNOLOGY
- Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
- (2017) Abhishek D. Garg et al. OncoImmunology
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
- (2016) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
- (2015) Guendalina Zuccari et al. JOURNAL OF CONTROLLED RELEASE
- Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
- (2014) A. Makkouk et al. CANCER RESEARCH
- Liposomal Bortezomib Nanoparticles via Boronic Ester Prodrug Formulation for Improved Therapeutic Efficacy in Vivo
- (2014) Jonathan D. Ashley et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction
- (2013) Biyin Cao et al. CURRENT PHARMACEUTICAL DESIGN
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
- (2011) Ulf Andersson et al. Annual Review of Immunology
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now